Review
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 7, 2013; 19(37): 6131-6143
Published online Oct 7, 2013. doi: 10.3748/wjg.v19.i37.6131
Table 1 Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in the prevention of rebleeding: Results from meta-analyses n (%)
Study findingReference, value
Burroughs et al[34]Zheng et al [35]
Patients948883
TIPS472440
Endoscopic therapies476443
Randomized controlled trials1312
Recurrent bleeding
TIPS88 (18.6)86 (19.0)
Endoscopic therapy210 (44.1)194 (43.8)
OR (95%CI) for TIPS0.30 (0.21-0.44)0.32 (0.24-0.43)
Post-treatment encephalopathy
TIPS134 (28.4)148 (33.6)
Endoscopic therapy83 (17.4)86 (19.4)
OR (95%CI) for TIPS2.08 (1.49-2.94)2.21 (1.61-3.03)
All-cause mortality
TIPS130 (27.5)111 (25.2)
Endoscopic therapy118 (24.8)98 (22.1)
OR (95%CI) for TIPS1.14 (0.85-1.54)1.17 (0.85-1.61)